Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

Meta Data (AIU) Stock Is Up 100% Today. What’s Going On?

Shares of AIU stock are surging today after the company carried out a reverse split. Some sympathy trading also appears to be taking place.

Trump Proposes a U.S. Strategic Bitcoin Reserve. What Would That Mean for BTC?

Former President Donald Trump recently discussed establishing a strategic Bitcoin reserve. Here's what investors need to know.

NVDA Stock: CEO Jensen Huang Is Set to Talk AI with Mark Zuckerberg. What to Watch.

Nvidia CEO Jensen Huang will soon have a discussion with Meta Platforms’ Mark Zuckerberg. The discussions could help NVDA stock.

TD Cowen Just Raised Its Price Target on Apple (AAPL) Stock

Apple stock is up on Monday after analysts at TD Cowen increase the firm's price target for AAPL shares ahead of its earnings report.

Why Is Beamr Imaging (BMR) Stock Moving Today?

Beamr Imaging stock is down on Monday after an early morning rally for BMR shares with an update on its video optimization.

HSBC Just Slashed Its Price Target on Tesla (TSLA) Stock to New Street Low

Tesla stock is up on Monday even as TSLA shares get hit with a lowered price target to $118 from HSBC analysts alongside a reduce rating.

MULN Stock Flirts with $1 as Mullen Files to Resell Up to 85 Million Shares

MULN stock is falling once again after the company announced the resale of up to 85 million shares. Here's what you need to know.

TLRY Stock: Tilray’s Aphria RX Receives Cannabis Trading License in Germany

Tilray stock is up on Monday after investors in TLRY learned of the company getting a new cannabis trading license in Germany.

PLTR Stock: Palantir Strikes New Green Energy Deal with TES

Palantir Technologies is teaming up with Tree Energy Solutions and gaining new clean energy exposure. Here's what this means for PLTR stock.

AMC Stock Pops as ‘Deadpool & Wolverine’ Brings a Major Box Office Boost

AMC stock is up slightly today after "Deadpool & Wolverine" broke several of the company's opening-weekend records.

Tivic Health Systems (TIVC) Stock Pops Another 39%

Tivic Health Systems stock is up on Monday with heavy trading of TIVC shares as recent volatility continues for the company's units.

RIVN Stock: German Regulators Sign Off on Volkswagen-Rivian Joint Venture

RIVN stock is in focus after Germany's competition authority approved the formation of a joint venture between Rivian and Volkswagen.

Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?

NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.

Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?

Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.

Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.

ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage.

Alibaba (BABA) Stock Rallies on Higher Fees. Why Investors Are Cheering.

BABA stock is climbing in early trading on news that Alibaba will impose a new fee on most of its China-based e-commerce vendors. 

Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates

The good news on Lomecel-B comes at an opportune time for Longeveron and LGVN stock -- it could attract a buyer.

Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?

LuxUrban Hotels stock is down on Monday after the company priced a public offering of LUXH shares below its prior closing price.

Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?

VTv Therapeutics stock is falling on Monday as VTVT investors react to the company's cadisegliatin clinical program being put on hold.